Zydus Lifesciences Ltd

Net income margin, %

17

2.8

EBITDA margin, %

24

10.8

Revenue CAGR 3Y, %

6.5

8.5

Revenue Y, % chg

11.3

0.5

P/E

32.9

22.7

P/BV

5.1

1.5

P/S

5.1

2.3

EV/S

5.2

2.4

EV/EBITDA

20.9

7.4

Average Analyst recommendation

Hold

Hold

Average upside forecasts, %

-19.8

51.3

Forward P/E

26.2

15.6

Dividend Yield, %

0.6

1.7

Forward Dividend Yield, %

0

0.2

Expected dividend per share

0

0

Dividend Ex Date

2023-07-28